Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain
This study has been terminated.
( Based on PK data, product did not meet requirement for further development. )
Study NCT00126789 Information provided by ZARS Pharma Inc.
First Received on August 2, 2005. Last Updated on June 4, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Physiological Effects of Drugs
Sensory System Agents
Sponsors listed in this trial
ZARS Pharma Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers